Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc.    crawled date : 2021 - 05 - 20    save search
List of Determinations Including Written Request
Published: 2021-05-20 (Crawled : 18:11) - fda.gov
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | | O: -0.43% H: 0.2% C: 0.02%
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: 0.61% H: 0.49% C: -1.46%
HOOKIPA to present Phase 1 safety, tolerability and preliminary anti-tumor activity data on HB-201 and HB-202 for the treatment of advanced HPV16+ cancers at ASCO
Published: 2021-05-20 (Crawled : 12:15) - biospace.com/
HOOK | $0.7317 -4.34% -4.54% 420K twitter stocktwits trandingview |
Health Technology
 | | O: -2.84% H: 0.54% C: -9.78%
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: 0.23% H: 1.92% C: 1.0%
treatment phase 1 cancer phase 3 phase 2
Everest Medicines Announces China NMPA Has Granted Priority Review for Sacituzumab Govitecan-hziy in Metastatic Triple-Negative Breast Cancer
Published: 2021-05-20 (Crawled : 11:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | | O: 0.23% H: 1.92% C: 1.0%
china cancer breast cancer granted grant
Gainers vs Losers
67% 33%

Top 10 Gainers
JOE 4 | $54.88 1.22% 0.22% 210K twitter stocktwits trandingview |
Finance
JBI 4 | $15.14 1.34% 0.0% 2.9M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.